A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies

While there has been significant progress in advancing novel immune therapies to the bedside, much more needs to be done to fully tap into the potential of the immune system. It has become increasingly clear that besides practical and operational challenges, the heterogeneity of cancer and the limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bot, Adrian, Ahn, Mark, Bosch, Marnix, Brockstedt, Dirk, Butterfield, Lisa H, Cornforth, Andrew, Harrop, Richard, Kast, W Martin, Koya, Richard, Marincola, Francesco, Margolin, Kim, McCoy, Candice, Pawelec, Graham, Rothman, John, Ramirez-Montagut, Teresa, Schlom, Jeffrey, Srivastava, Pramod, Wallis, Sarah, Walter, Steffen, Wang, Ena, Waslif, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551774/
https://www.ncbi.nlm.nih.gov/pubmed/23127127
http://dx.doi.org/10.1186/1479-5876-10-218

Ejemplares similares

Ejemplares similares